Portfolio

With a passion for innovating technology and a clear understanding of business dynamics, Qbic supports researchers and entrepreneurs in transforming technological breakthroughs into successful companies.

Tanai Therapeutics

Qbic III
3
Biotech
Biotech
Biotech
Biotech

Tanai Therapeutics

Tanai Therapeutics is developing a first-in-class oral therapeutic for obesity.

Universiteit Gent
Universiteit Gent
Flindr Therapeutics

Qbic III
3
0
Biotech
Biotech
Biotech
Biotech

Flindr Therapeutics

Flindr aims to restore a patient’s impaired immune response to cancer

Universiteit Gent
Universiteit Gent
AmphiStar

Qbic III
3
Biotech
Biotech
Biotech
Biotech

AmphiStar

AmphiStar offers a portfolio of locally sourced biosurfactants to companies seeking to develop sustainable, performant & affordable products

Universiteit Gent
Universiteit Gent
Obulytix

Qbic III
3
0
Biotech
Biotech
Biotech
Biotech

Obulytix

Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.

Universiteit Gent
Universiteit Gent
Axithra

Qbic III
3
0
HealthTech
HealthTech
HealthTech
HealthTech

Axithra

Axithra is developing new technology for accurate drug concentrations in blood.

Universiteit Gent
Universiteit Gent
imec
imec
VoxelSensors

"Our goal at VoxelSensors is to seamlessly integrate the physical and digital worlds to a point level where they become indistinguishable."

Johannes Peeters, CEO

Qbic III
3
0
Deeptech
Deeptech
Deeptech
Deeptech

VoxelSensors

VoxelSensors is developing ultra-low power and ultra-low latency 3D perception sensors for Extended Reality.

VUB
VUB
Animab

Qbic III
3
0
Biotech
Biotech
Biotech
Biotech

Animab

Animab develops antibodies to tackle gastrointestinal pathogens in livestock.

Universiteit Gent
Universiteit Gent
VUB
VUB
Weavely

Qbic III
3
Software
Software
Software
Software

Weavely

Weavely helps companies test and validate digital products before launch.

VUB
VUB
THERAtRAME

Qbic III
0
3
0
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

ULiège
ULiège
Swave

"Swave’s HXR gigapixel technology will forever change the way we see and experience displayed still images, videos and live imaging."

Theo Marescaux, CEO

Qbic III
0
3
0
Deeptech
Deeptech
Deeptech
Deeptech

Swave

Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.

imec
imec
VUB
VUB
Cascador Health

Qbic II
2
HealthTech
HealthTech
HealthTech
HealthTech

Cascador Health

Cascador Health bridges the gap between data sources and the users of healthcare data.

Universiteit Gent
Universiteit Gent
Ziekenhuispartner
Trince

"Our technology has the potential to enhance the therapeutic effectiveness of cell-based therapies and make them more affordable.”

Prof. Kevin Braeckmans

Qbic II
2
Biotech
Biotech
Biotech
Biotech

Trince

Trince developed a new transfection technology based on a combination of laser light and photothermal nanoparticles.

Universiteit Gent
Universiteit Gent
CrowdScan

Qbic II
2
Software
Software
Software
Software

CrowdScan

CrowdScan provides accurate and privacy-friendly crowd measurement data.

Universiteit Antwerpen
Universiteit Antwerpen
imec
imec
moveUP

"As the first-ever digital health app to be reimbursed in Belgium, we are setting the standard for healthcare’s transition to value-based (digital) care."

Ward Servaes, CEO

Qbic II
2
HealthTech
HealthTech
HealthTech
HealthTech

moveUP

moveUP develops personalized remote digital care for patients undergoing surgery and other interventions.

AZ Maria Middelares
AZ Maria Middelares
VUB
VUB
Ziekenhuispartner
Accelleran

Qbic II
2
Software
Software
Software
Software

Accelleran

Accelleran provides OpenRAN Software solutions for operators of 5G networks.

Universiteit Antwerpen
Universiteit Antwerpen
imec
imec
Abscint

Qbic II
2
Biotech
Biotech
Biotech
Biotech

Abscint

ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.

VUB
VUB
UZ Brussel
UZ Brussel
Ziekenhuispartner
Indigo

"Managing diabetes should be as easy as possible, and that is what we want to help accomplish."

Danaë Delbeke, CEO

Qbic I & II
1
2
HealthTech
HealthTech
HealthTech
HealthTech

Indigo

Indigo is developing an implantable sensor that allows to continuously measure glucose and other metabolites for up to two years.

Universiteit Gent
Universiteit Gent
imec
imec
MRM Health

Qbic II
2
Biotech
Biotech
Biotech
Biotech

MRM Health

MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.

Universiteit Gent
Universiteit Gent
QustomDot

"MicroLED displays could take out all the currently available display types. It would be great if QustomDot could facilitate this.”

Kim de Nolf, CEO

Qbic II
2
Deeptech
Deeptech
Deeptech
Deeptech

QustomDot

QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.

Universiteit Gent
Universiteit Gent
Calltic

Qbic II
2
Software
Software
Software
Software

Calltic

Calltic developed an acoustic analysis method allowing to quickly and accurately detect telecom fraud.

Universiteit Gent
Universiteit Gent
UniD Manufacturing

"There was no equipment on the market to manufacture implants at a micrometer dimension, so we built it ourselves."

Mélanie Mestdagt, CEO

Qbic II
2
HealthTech
HealthTech
HealthTech
HealthTech

UniD Manufacturing

UniD Manufacturing is developing and manufacturing micro-implants.

ULiège
ULiège